KR20010101468A - 비시클릭 화합물의 제조 방법 및 이 방법의인터루킨-1Sg(B) 전환 효소 (ICE) 억제제를제조하기 위한 용도 - Google Patents
비시클릭 화합물의 제조 방법 및 이 방법의인터루킨-1Sg(B) 전환 효소 (ICE) 억제제를제조하기 위한 용도 Download PDFInfo
- Publication number
- KR20010101468A KR20010101468A KR1020017008755A KR20017008755A KR20010101468A KR 20010101468 A KR20010101468 A KR 20010101468A KR 1020017008755 A KR1020017008755 A KR 1020017008755A KR 20017008755 A KR20017008755 A KR 20017008755A KR 20010101468 A KR20010101468 A KR 20010101468A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- iopt
- dioxo
- ethyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 35
- 238000006243 chemical reaction Methods 0.000 title description 5
- 108090000790 Enzymes Proteins 0.000 title description 2
- 102000004190 Enzymes Human genes 0.000 title description 2
- 125000002619 bicyclic group Chemical group 0.000 title description 2
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 68
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 13
- 125000003118 aryl group Chemical group 0.000 claims abstract description 11
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 10
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 claims abstract description 7
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 4
- 238000004519 manufacturing process Methods 0.000 claims abstract description 3
- -1 aralkyl radical Chemical class 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 19
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 claims description 15
- 125000003277 amino group Chemical group 0.000 claims description 11
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical group CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 10
- 150000003009 phosphonic acids Chemical class 0.000 claims description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 125000005544 phthalimido group Chemical group 0.000 claims description 6
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 150000005840 aryl radicals Chemical class 0.000 claims description 4
- 230000005595 deprotonation Effects 0.000 claims description 4
- 238000010537 deprotonation reaction Methods 0.000 claims description 4
- 238000007327 hydrogenolysis reaction Methods 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- ICDLEMPZXFCQEB-VIFPVBQESA-N 2-[(3s)-2,6-dioxooxan-3-yl]isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1[C@H]1CCC(=O)OC1=O ICDLEMPZXFCQEB-VIFPVBQESA-N 0.000 claims description 3
- 150000008064 anhydrides Chemical class 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- IIVWHGMLFGNMOW-UHFFFAOYSA-N 2-methylpropane Chemical group C[C](C)C IIVWHGMLFGNMOW-UHFFFAOYSA-N 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- SEBZFJOSVQSWRI-UHFFFAOYSA-N ethyl 7-(1,3-dioxoisoindol-2-yl)-6,10-dioxo-2,7,8,9-tetrahydro-1h-pyridazino[1,2-a]diazepine-4-carboxylate Chemical compound CCOC(=O)C1=CCCN(C(CC2)=O)N1C(=O)C2N1C(=O)C2=CC=CC=C2C1=O SEBZFJOSVQSWRI-UHFFFAOYSA-N 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 239000011593 sulfur Substances 0.000 claims description 2
- 239000013638 trimer Substances 0.000 claims description 2
- 150000001412 amines Chemical group 0.000 abstract description 12
- 108090000426 Caspase-1 Proteins 0.000 abstract description 4
- 102100035904 Caspase-1 Human genes 0.000 abstract description 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 229940042400 direct acting antivirals phosphonic acid derivative Drugs 0.000 abstract 1
- 150000003007 phosphonic acid derivatives Chemical class 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 33
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 238000003756 stirring Methods 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 239000000460 chlorine Substances 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 239000012429 reaction media Substances 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- FEFFSKLJNYRHQN-UHFFFAOYSA-N 2-Phthalimidoglutaricacid Chemical compound C1=CC=C2C(=O)N(C(CCC(=O)O)C(O)=O)C(=O)C2=C1 FEFFSKLJNYRHQN-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- IMJLPXIWIIDKHO-UHFFFAOYSA-N ethyl 2,5-dibromopentanoate Chemical compound CCOC(=O)C(Br)CCCBr IMJLPXIWIIDKHO-UHFFFAOYSA-N 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QIWKCQDJZPRXNS-VIFPVBQESA-N (2s)-2-[(2-carboxybenzoyl)amino]pentanedioic acid Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)C1=CC=CC=C1C(O)=O QIWKCQDJZPRXNS-VIFPVBQESA-N 0.000 description 1
- LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 description 1
- JDAVNLLRFXIKKD-UHFFFAOYSA-N 2,5-dibromopentanoic acid Chemical compound OC(=O)C(Br)CCCBr JDAVNLLRFXIKKD-UHFFFAOYSA-N 0.000 description 1
- KTEHZYXPFUSILF-UHFFFAOYSA-N 2-isoindol-2-ylacetic acid Chemical compound C1=CC=CC2=CN(CC(=O)O)C=C21 KTEHZYXPFUSILF-UHFFFAOYSA-N 0.000 description 1
- WNXNUPJZWYOKMW-UHFFFAOYSA-N 5-bromopentanoic acid Chemical compound OC(=O)CCCCBr WNXNUPJZWYOKMW-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 1
- DRUIXHONAHEYCH-UHFFFAOYSA-N C1CC(N(N(C1)C(=O)OCC2=CC=CC=C2)C(=O)O)C(=O)O Chemical compound C1CC(N(N(C1)C(=O)OCC2=CC=CC=C2)C(=O)O)C(=O)O DRUIXHONAHEYCH-UHFFFAOYSA-N 0.000 description 1
- DRUIXHONAHEYCH-NSHDSACASA-N C1C[C@H](N(N(C1)C(=O)OCC2=CC=CC=C2)C(=O)O)C(=O)O Chemical compound C1C[C@H](N(N(C1)C(=O)OCC2=CC=CC=C2)C(=O)O)C(=O)O DRUIXHONAHEYCH-NSHDSACASA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000003777 Interleukin-1 beta Human genes 0.000 description 1
- 108090000193 Interleukin-1 beta Proteins 0.000 description 1
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 1
- FEFFSKLJNYRHQN-VIFPVBQESA-N N-phthaloyl-L-glutamic acid Chemical compound C1=CC=C2C(=O)N([C@@H](CCC(=O)O)C(O)=O)C(=O)C2=C1 FEFFSKLJNYRHQN-VIFPVBQESA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000012351 deprotecting agent Substances 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- QRKPPWPLSQRGSU-UHFFFAOYSA-N diazepine-1-carboxylic acid Chemical compound OC(=O)N1C=CC=CC=N1 QRKPPWPLSQRGSU-UHFFFAOYSA-N 0.000 description 1
- GTABLZQCIHCVPN-UHFFFAOYSA-N diazinane-1,2,3-tricarboxylic acid Chemical compound OC(=O)C1CCCN(C(O)=O)N1C(O)=O GTABLZQCIHCVPN-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000006345 epimerization reaction Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (16)
- 하기 화학식 (IA)의 화합물로부터 출발하여 염기성 매질에서 하기 화학식 (P1)의 포스폰산의 유도체 또는 하기 화학식 (P2)의 트라이머의 존재하에 고리화가 수행되는 것을 특징으로 하는 하기 화학식 (I)의 화합물의 제조 방법.<화학식 I><화학식 IA><화학식 P1>P(=Z)(X1)(X2)(X3)<화학식 P2>식 중에서,R은 수소 원자, 18 개 이하의 탄소 원자를 함유하는 알킬, 아릴 또는 아르알킬 라디칼이고,아민 관능기는 유리되거나 보호될 수 있으며,Z는 황 또는 산소 원자이고,X1은 할로겐 원자이고,X2및 X3는 동일하거나 상이하며, 할로겐 원자, 1 내지 6 개의 탄소 원자를 함유하는 알킬옥시 라디칼, 6 내지 12 개의 탄소 원자를 함유하는 아릴옥시 라디칼 또는 7 내지 15 개의 탄소 원자를 함유하는 아릴알킬옥시 라디칼을 나타낸다.
- 제1항에 있어서, (P1)이 POCl3인 방법.
- 제1항에 있어서, (P1)이 POBr3인 방법.
- 제1항 내지 제3항 중 어느 한 항에 있어서, 염기가 피리딘 또는 2,6-루티딘으로부터 선택되는 방법.
- 제1항 내지 제4항 중 어느 한 항에 있어서, 고리화 온도가 70 및 80 ℃ 사이에 포함되는 것을 특징으로 하는 방법.
- 제1항 내지 제4항 중 어느 한 항에 있어서, 용매가 디클로로에탄인 것을 특징으로 하는 방법.
- 제1항에서 기재된 바와 같은 고리화 방법을 포함하고,a) 하기 화학식 (II)의 화합물을 하기 화학식 (III)의 화합물과 반응시켜 S 및 R 입체이성질체 혼합물의 형태의 하기 화학식 (IV)의 화합물을 수득하는 단계,b) 하기 화학식 (IV)의 화합물을 아민 관능기가 보호되거나 비보호된 형태인 화학식 (F)의 무수물과 반응시키면서 가수소분해에 의한 탈양성자화를 수행하여 제1항에서 기술된 바와 같은 하기 화학식 (IA)의 화합물을 수득하는 단계,c) 제1항에 따른 화학식 (IA)의 화합물을 제4항에 따른 염기의 존재하에 제1항 내지 제3항 중 어느 한 항에 따른 포스폰산 (P1) 또는 (P2)의 유도체와 반응시켜 제1항에서 정의된 하기 화학식 (I)의 화합물을 수득하는 단계,d) 적절한 경우, 아민 관능기를 탈보호시켜 아민 관능기가 보호되지 않은 화학식 (I)의 화합물을 수득하는 단계,e) 적절한 경우, SS + SR 또는 SR 형태의 화학식 (I)의 화합물을 탈라세미화제 및(또는) 에피머화제와 반응시켜 SS 부분입체이성질체에 상응하는 하기 화학식 (Iopt)의 화합물을 수득하는 단계,f) 적절한 경우, 아민 관능기를 탈보호시켜 아민 관능기가 보호되지 않은 화학식 (Iopt)의 화합물을 수득하는 단계를 포함하는 것을 특징으로 하는 라세미 또는 광학 활성 (Iopt) 형태의 화학식 (I)의 화합물의 제조 방법.<화학식 II><화학식 III><화학식 IV><화학식 F><화학식 IA><화학식 I><화학식 Iopt>식 중에서,R은 제1항에서 정의된 바와 같으며,Hal은 할로겐 원자를 나타내며,아릴은 14 개 이하의 탄소 원자를 함유하는 아릴 라디칼을 나타낸다.
- 제7항에 있어서, F가 N-프탈로일-L-글루탐산 무수물인 방법.
- 제1항 내지 제8항 중 어느 한 항에 있어서, 화학식 (IA), (I) 및 (Iopt)의 화합물의 아민 관능기가 프탈이미도 형태로 보호된 것인 방법.
- 제1항 내지 제8항 중 어느 한 항에 있어서, 화학식 (II), (IV), (IA), (I) 및 (Iopt)의 화합물 중, R이 메틸, 에틸 또는 tert부틸 라디칼인 방법.
- 제1항 내지 제8항 중 어느 한 항에 있어서, 화학식 (I)의 화합물이 에틸-9-(1,3-디히드로-1,3-디옥소-2H-이소인돌-2-일)-3,4,7,8,9,10-헥사히드로-6,10-디옥소-6H-피리다지노-[1,2-a][1,2]디아제핀-1-카르복실레이트인 방법.
- 제1항 내지 제8항 중 어느 한 항에 있어서, 화학식 (Iopt)의 화합물이 에틸-(1S-시스)-9-(1,3-디히드로-1,3-디옥소-2H-이소인돌-2-일)-3,4,7,8,9,10-헥사히드로-6,10-디옥소-6H-피리다지노-[1,2-a][1,2]디아제핀-1-카르복실레이트인 방법.
- 제1항 내지 제12항 중 어느 한 항에 따른 방법의 제7항에서 정의된 바와 같은 화학식 (Iopt)의 화합물을 통하여 화학식 (V)의 화합물의 제조를 위한 중간 단계로서의 용도.<화학식 V>
- 제13항에 있어서, 화학식 (Iopt)의 화합물이 에틸-(1S-시스)-9-(1,3-디히드로-1,3-디옥소-2H-이소인돌-2-일)-3,4,7,8,9,10-헥사히드로-6,10-디옥소-6H-피리다지노-[1,2-a][1,2]디아제핀-1-카르복실레이트인 것을 특징으로 하는 용도.
- 제1항 내지 제6항 중 어느 한 항에 따른 방법의 제7항 내지 제14항 중 어느 한 항에서 정의된 바와 같은 화학식 (I) 및 (Iopt)의 화합물에 대한 전체 제조 방법의 중간 단계로서의 용도.
- 제1항에서 정의된 바와 같은 화학식 (IA)의 화합물.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR99/00227 | 1999-01-12 | ||
FR9900227A FR2788276B1 (fr) | 1999-01-12 | 1999-01-12 | NOUVEAU PROCEDE DE PREPARATION DE COMPOSES BICYCLIQUES ET L'APPLICATION DE CE PROCEDE COMME ETAPE INTERMEDIAIRE POUR LA PREPARATION D'UN COMPOSE INHIBITEUR DE L'ENZYME DE CONVERSION DE L'INTERLEUKINE 1-BETA (ice) |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010101468A true KR20010101468A (ko) | 2001-11-14 |
KR100797349B1 KR100797349B1 (ko) | 2008-01-22 |
Family
ID=9540778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020017008755A KR100797349B1 (ko) | 1999-01-12 | 2000-01-11 | 비시클릭 화합물의 제조 방법 및 이 방법의인터루킨-1Sg(B) 전환 효소 (ICE) 억제제를제조하기 위한 용도 |
Country Status (24)
Country | Link |
---|---|
US (1) | US6512111B1 (ko) |
EP (1) | EP1144436B1 (ko) |
JP (1) | JP4601826B2 (ko) |
KR (1) | KR100797349B1 (ko) |
CN (1) | CN1240710C (ko) |
AT (1) | ATE263780T1 (ko) |
AU (1) | AU774752B2 (ko) |
BR (1) | BR0007810B1 (ko) |
CA (1) | CA2359964C (ko) |
DE (1) | DE60009658T2 (ko) |
DK (1) | DK1144436T3 (ko) |
ES (1) | ES2215020T3 (ko) |
FR (1) | FR2788276B1 (ko) |
HK (1) | HK1045316B (ko) |
HU (1) | HU230062B1 (ko) |
IL (2) | IL144227A0 (ko) |
NO (1) | NO328110B1 (ko) |
NZ (1) | NZ512908A (ko) |
PL (1) | PL196993B1 (ko) |
PT (1) | PT1144436E (ko) |
SI (1) | SI1144436T1 (ko) |
TW (1) | TWI222443B (ko) |
WO (1) | WO2000042061A1 (ko) |
ZA (1) | ZA200105550B (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6703500B2 (en) | 1998-08-19 | 2004-03-09 | Vertex Pharmaceuticals, Incorporated | Method of preparing bicyclic intermediates from piperazic acid or an ester thereof useful in the manufacture of caspase inhibitors |
US6559304B1 (en) | 1998-08-19 | 2003-05-06 | Vertex Pharmaceuticals Incorporated | Method for synthesizing caspase inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA833214B (en) * | 1982-05-12 | 1983-12-28 | Hoffmann La Roche | Bicyclic compounds |
GB2128984B (en) * | 1982-05-12 | 1985-05-22 | Hoffmann La Roche | Diaza-bicyclic compounds |
-
1999
- 1999-01-12 FR FR9900227A patent/FR2788276B1/fr not_active Expired - Fee Related
- 1999-12-10 TW TW088121699A patent/TWI222443B/zh not_active IP Right Cessation
-
2000
- 2000-01-11 NZ NZ512908A patent/NZ512908A/en not_active IP Right Cessation
- 2000-01-11 ES ES00900552T patent/ES2215020T3/es not_active Expired - Lifetime
- 2000-01-11 EP EP00900552A patent/EP1144436B1/fr not_active Expired - Lifetime
- 2000-01-11 US US09/869,950 patent/US6512111B1/en not_active Expired - Lifetime
- 2000-01-11 WO PCT/FR2000/000041 patent/WO2000042061A1/fr active IP Right Grant
- 2000-01-11 CN CNB008048320A patent/CN1240710C/zh not_active Expired - Fee Related
- 2000-01-11 CA CA2359964A patent/CA2359964C/fr not_active Expired - Fee Related
- 2000-01-11 SI SI200030348T patent/SI1144436T1/xx unknown
- 2000-01-11 BR BRPI0007810-7A patent/BR0007810B1/pt not_active IP Right Cessation
- 2000-01-11 AU AU30524/00A patent/AU774752B2/en not_active Ceased
- 2000-01-11 AT AT00900552T patent/ATE263780T1/de active
- 2000-01-11 JP JP2000593628A patent/JP4601826B2/ja not_active Expired - Fee Related
- 2000-01-11 DK DK00900552T patent/DK1144436T3/da active
- 2000-01-11 KR KR1020017008755A patent/KR100797349B1/ko not_active IP Right Cessation
- 2000-01-11 DE DE60009658T patent/DE60009658T2/de not_active Expired - Lifetime
- 2000-01-11 PT PT00900552T patent/PT1144436E/pt unknown
- 2000-01-11 HU HU0202665A patent/HU230062B1/hu not_active IP Right Cessation
- 2000-01-11 PL PL348919A patent/PL196993B1/pl unknown
- 2000-01-11 IL IL14422700A patent/IL144227A0/xx active IP Right Grant
-
2001
- 2001-07-05 ZA ZA200105550A patent/ZA200105550B/en unknown
- 2001-07-10 IL IL144227A patent/IL144227A/en not_active IP Right Cessation
- 2001-07-11 NO NO20013435A patent/NO328110B1/no not_active IP Right Cessation
-
2002
- 2002-09-18 HK HK02106828.3A patent/HK1045316B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0354583B1 (en) | DC-88A derivatives | |
FR2748026A1 (fr) | Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
KR100474496B1 (ko) | S형2-치환히드록시-2-인돌리디닐부티르산에스테르화합물및이의제조방법 | |
KR100797349B1 (ko) | 비시클릭 화합물의 제조 방법 및 이 방법의인터루킨-1Sg(B) 전환 효소 (ICE) 억제제를제조하기 위한 용도 | |
KR100561582B1 (ko) | 신규한옥타히드로-6,10-디옥소-6H-피리다지노[1,2-a][1,2]디아제핀-1-카르복실산 유도체, 그의 제조 방법 및 치료적 활성화합물의 제조용 용도 | |
US4873356A (en) | Method for preparing phosphinic acids used in preparing ace inhibitors and intermediates produced thereby | |
KR0179368B1 (ko) | 포스핀산 에스테르의 부분 입체 이성질체의 선택적 제조방법 | |
JP2842640B2 (ja) | β―ラクタム抗生物質の溶媒和物 | |
CA2190202C (en) | Cyclopentenecarboxamide derivative, method for preparing the same and bicycloamide derivative used therein | |
JPS5833877B2 (ja) | ユウキカゴウブツニカンスルカイリヨウ | |
MXPA01007052A (en) | METHOD FOR PREPARING BICYCLIC COMPOUNDS AND USE OF SAID METHOD FOR PREPARING AN INTERLEUKIN-1$g(B) CONVERSION ENZYME (ICE) INHIBITOR | |
KR100219251B1 (ko) | 광학 활성 1,6-나프티리딘 유도체 | |
KR0150460B1 (ko) | 라세믹 및 광학활성인 옥타히드로-인돌로[2,3-a]테트라히드로 피라닐 [2,3-c]퀴놀리진 디에스테르 유도체와 그의 산부가염 및 그의 제조방법 | |
IL99535A (en) | Preparation of S)] - 21 (-3- Mercapto-methyl- 1- Oxopropyl [- L- Proline and intermediate material obtained | |
FI85264C (fi) | Foerfarande foer framstaellning av n-asyl-l-prolinderivat. | |
KR100355533B1 (ko) | 뉴클레오시드 유사체의 입체선택적 합성방법 | |
KR0161351B1 (ko) | 신규 티아(디아)졸 초산의 반응성 포스페이트 유도체 및 그의 제조방법 | |
JPH06741B2 (ja) | インド−ル類の製造方法 | |
JP2654847B2 (ja) | 新規イソキノリン誘導体 | |
WO1997046559A1 (en) | Process for preparing 9-hydroxyellipticine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121226 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20131220 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20141231 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20151217 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20161220 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20171219 Year of fee payment: 11 |
|
LAPS | Lapse due to unpaid annual fee |